{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:11:54Z","timestamp":1788487914191,"version":"build-2803163510"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011568","name":"Ministry of Ecological Transition and Territorial Cohesion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tiv.2026.106272","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:38:15Z","timestamp":1781800695000},"page":"106272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pulmonary permeability assessment using two human lung epithelial cell models in air-liquid interface cultures"],"prefix":"10.1016","volume":"116","author":[{"given":"R.","family":"Boufalaas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Floreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Ravi Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sarigiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Karakitsios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Escher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vayssade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-A.","family":"Billat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2026.106272_bb0005","article-title":"The effect of Thymbra spicata extract and its bioactive component thymol on non-small-cells lung cancer cell line A549","author":"Ardeshir","year":"2021","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.tiv.2026.106272_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.201900026","article-title":"Capturing the onset of bacterial pulmonary infection in acini-on-chips","volume":"3","author":"Artzy-Schnirman","year":"2019","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.tiv.2026.106272_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-23768-4","article-title":"A human relevant in vitro alveolar epithelial barrier model to assess inhaled pollutant hazard","volume":"15","author":"Bateman","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2026.106272_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.tox.2010.04.004","article-title":"Human primary bronchial lung cell constructs: the new respiratory models","volume":"278","author":"B\u00e9rub\u00e9","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2026.106272_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2026.1764276","article-title":"NAMs for closing knowledge gaps in assessment of respiratory uptake\u2013a PARC project","volume":"8","author":"Billat","year":"2026","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.tiv.2026.106272_bb0030","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1007\/s11095-017-2251-y","article-title":"A comparison of drug transport in pulmonary absorption models: isolated perfused rat lungs, respiratory epithelial cell lines and primary cell culture","volume":"34","author":"Bosquillon","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2026.106272_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2025.106122","article-title":"Comparison of the behavior of human lung epithelial cell lines cultured at the air-liquid interface and assessment of their responses after benzo(a)pyrene exposure","volume":"109","author":"Boul\u00e9","year":"2025","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2026.106272_bb0040","doi-asserted-by":"crossref","DOI":"10.3791\/61210","article-title":"An air-liquid interface bronchial epithelial model for realistic, repeated inhalation exposure to airborne particles for toxicity testing","author":"Braakhuis","year":"2020","journal-title":"J. Vis. Exp."},{"issue":"2","key":"10.1016\/j.tiv.2026.106272_bb0045","first-page":"280","article-title":"Chemical fate in vitro: a physiological biokinetic (PBK) model for cell-based assays","volume":"43","author":"Brenner","year":"2026","journal-title":"Altex"},{"key":"10.1016\/j.tiv.2026.106272_bb0050","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1021\/tx300221k","article-title":"Transport of chlorpromazine in the Caco-2 cell permeability assay: a kinetic study","volume":"25","author":"Broeders","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2026.106272_bb0055","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.tiv.2013.01.010","article-title":"In vitro biokinetics of chlorpromazine and the influence of different dose metrics on effect concentrations for cytotoxicity in Balb\/c 3T3, Caco-2 and HepaRG cell cultures","volume":"27","author":"Broeders","year":"2013","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2026.106272_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248798","article-title":"Co-culture of type I and type II pneumocytes as a model of alveolar epithelium","volume":"16","author":"Brookes","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.tiv.2026.106272_bb0065","article-title":"A monoclonal human alveolar epithelial cell line (\u201cArlo\u201d) with pronounced barrier function for studying drug permeability and viral infections","volume":"10","author":"Carius","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.tiv.2026.106272_bb0070","series-title":"Basic Physiology for Anaesthetists","first-page":"21","article-title":"Lung anatomy and function","author":"Chambers","year":"2015"},{"key":"10.1016\/j.tiv.2026.106272_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2023.104281","article-title":"3D model of the bronchial epithelial barrier to study repeated exposure to xenobiotics: application to silver nanoparticles","volume":"103","author":"Chiv\u00e9","year":"2023","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2026.106272_bb0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tiv.2011.12.002","article-title":"In vitro metabolism of di(2-ethylhexyl) phthalate (DEHP) by various tissues and cytochrome P450s of human and rat","volume":"26","author":"Choi","year":"2012","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2026.106272_bb0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tiv.2016.07.013","article-title":"Theoretical and mathematical foundation of the virtual cell based assay \u2013 a review","volume":"45","author":"Comenges","year":"2017","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2026.106272_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2023.121017","article-title":"Mechanistic insights into the adsorption of endocrine disruptors onto polystyrene microplastics in water","volume":"319","author":"Cort\u00e9s-Arriagada","year":"2023","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.tiv.2026.106272_bb0095","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1021\/acs.est.0c06117","article-title":"Designing QSARs for parameters of high-throughput toxicokinetic models using open-source descriptors","volume":"55","author":"Dawson","year":"2021","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.tiv.2026.106272_bb0100","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Lysosomotropic agents","volume":"23","author":"De Duve","year":"1974","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2026.106272_bb0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.toxrep.2014.03.003","article-title":"Assessment of an in vitro model of pulmonary barrier to study the translocation of nanoparticles","volume":"1","author":"Dekali","year":"2014","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.tiv.2026.106272_bb0110","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.31083\/ph.2012.2534","article-title":"Identification of CYP isoforms involved in the metabolism of thymol and carvacrol in human liver microsomes (HLMs)","volume":"67","author":"Dong","year":"2012","journal-title":"Pharmazie"},{"key":"10.1016\/j.tiv.2026.106272_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/089426802320282257","article-title":"Drug absorption by the respiratory mucosa: cell culture models and particulate drug carriers","volume":"15","author":"Ehrhardt","year":"2002","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.tiv.2026.106272_bb0120","series-title":"Inhaled Medicines","article-title":"Epithelial permeability and drug absorption in the lungs","author":"Enlo-Scott","year":"2021"},{"key":"10.1016\/j.tiv.2026.106272_bb0125","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1021\/jm040760a","article-title":"Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction","volume":"47","author":"Ermondi","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tiv.2026.106272_bb0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tiv.2019.06.006","article-title":"Comparative analysis of rapid equilibrium dialysis (RED) and solid phase micro-extraction (SPME) methods for in vitro-in vivo extrapolation of environmental chemicals","volume":"60","author":"Ferguson","year":"2019","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2026.106272_bb0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-3659(02)00356-5","article-title":"Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3","volume":"87","author":"Florea","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tiv.2026.106272_bb0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5173(03)00129-7","article-title":"The human bronchial epithelial cell line 16HBE14o- as a model system of the airways for studying drug transport","volume":"257","author":"Forbes","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tiv.2026.106272_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00452-X","article-title":"Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery","volume":"208","author":"Foster","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tiv.2026.106272_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0034-5687(78)90104-4","article-title":"The normal human lung: ultrastructure and morphometric estimation of diffusion capacity","volume":"32","author":"Gehr","year":"1978","journal-title":"Respir. Physiol."},{"key":"10.1016\/j.tiv.2026.106272_bb0155","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/acs.molpharmaceut.6b00724","article-title":"Relationship between passive permeability and molecular polarity using block relevance analysis","volume":"14","author":"Goetz","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tiv.2026.106272_bb0160","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11095-006-0255-0","article-title":"Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier","volume":"23","author":"Grainger","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2026.106272_bb0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1289\/ehp.8877151","article-title":"The in vitro serum protein-binding characteristics of bis-(2-ethylhexyl) phthalate and its principal metabolite, mono-(2-ethylhexyl) phthalate","volume":"77","author":"Griffiths","year":"1988","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tiv.2026.106272_bb0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tox.2013.08.012","article-title":"Dose metric considerations in in vitro assays to improve quantitative in vitro\u2013in vivo dose extrapolations","volume":"332","author":"Groothuis","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2026.106272_bb0175","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/toxics11050441","article-title":"Distribution of micro-nano PS, DEHP, and\/or MEHP in mice and nerve cell models in vitro after exposure to micro-nano PS and DEHP","volume":"11","author":"Han","year":"2023","journal-title":"Toxics"},{"key":"10.1016\/j.tiv.2026.106272_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2024.1355044","article-title":"The (misleading) role of animal models in drug development","volume":"4","author":"Hartung","year":"2024","journal-title":"Front. Drug Discov."},{"key":"10.1016\/j.tiv.2026.106272_bb0185","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1111\/febs.14582","article-title":"A guide to polarized airway epithelial models for studies of host-pathogen interactions","volume":"285","author":"Hasan","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.tiv.2026.106272_bb0190","article-title":"Scope and relevance of a pulmonary biopharmaceutical classification system AAPS\/FDA\/USP workshop march 16-17th, 2015 in Baltimore, MD","volume":"2","author":"Hastedt","year":"2016","journal-title":"AAPS Open"},{"key":"10.1016\/j.tiv.2026.106272_bb0195","series-title":"Molecular, Clinical and Environmental Toxicology: Volume 2: Clinical Toxicology","first-page":"461","article-title":"Inhalation toxicology","author":"Hayes","year":"2010"},{"key":"10.1016\/j.tiv.2026.106272_bb0200","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1124\/jpet.108.145797","article-title":"Kinetics of cellular retention during Caco-2 permeation experiments: role of lysosomal sequestration and impact on permeability estimates","volume":"328","author":"Heikkinen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2026.106272_bb0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tiv.2017.11.005","article-title":"Human lung epithelial cell cultures for analysis of inhaled toxicants: lessons learned and future directions","volume":"47","author":"Hiemstra","year":"2018","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2026.106272_bb0210","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tiv.2026.106272_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfaf113","article-title":"Are new approach methodologies (NAMs) the holy grail of toxicology?","volume":"208","author":"Jaeschke","year":"2025","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2026.106272_bb0220","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1021\/acs.jcim.4c01815","article-title":"Permeability benchmarking: guidelines for comparing in silico, in vitro, and in vivo measurements","volume":"65","author":"Jorgensen","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.tiv.2026.106272_bb0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jchromb.2016.09.036","article-title":"Method development and validation for simultaneous quantitation of endogenous hippuric acid and phenylacetylglycine in rat urine using liquid chromatography coupled with electrospray ionization tandem mass spectrometry","volume":"1035","author":"Kamiguchi","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.tiv.2026.106272_bb0230","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1358\/mf.2003.25.7.778088","article-title":"Propranolol cytotoxicity in rat and human lung in vitro","volume":"25","author":"Kastelova","year":"2003","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2026.106272_bb0235","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drudis.2012.11.008","article-title":"The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so","volume":"18","author":"Kell","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tiv.2026.106272_bb0240","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1124\/dmd.108.020834","article-title":"Hepatocellular binding of drugs: correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data","volume":"36","author":"Kilford","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2026.106272_bb0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pupt.2011.12.003","article-title":"Role of epithelial mucins during airway infection","volume":"25","author":"Kim","year":"2012","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2026.106272_bb0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.14573\/altex.1607191","article-title":"Co-culture of human alveolar epithelial (hAELVi) and macrophage (THP-1) cell lines","volume":"35","author":"Kletting","year":"2018","journal-title":"Altex"},{"key":"10.1016\/j.tiv.2026.106272_bb0255","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1111\/cts.13616","article-title":"Deriving protein binding-corrected chemical concentrations for in vitro testing","volume":"16","author":"Kolli","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.tiv.2026.106272_bb0260","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/tx200479k","article-title":"Quantifying processes determining the free concentration of phenanthrene in basal cytotoxicity assays","volume":"25","author":"Kramer","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2026.106272_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2014.12.017","article-title":"The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function","volume":"69","author":"Kreft","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2026.106272_bb0270","first-page":"251","article-title":"Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier","volume":"33","author":"Kuehn","year":"2016","journal-title":"Altex"},{"key":"10.1016\/j.tiv.2026.106272_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/cells14050336","article-title":"Systematic comparison of FBS and medium variation effect on key cellular processes using morphological profiling","volume":"14","author":"Lebedev","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.tiv.2026.106272_bb0280","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejpb.2019.09.001","article-title":"Assessment of the feasibility to develop a fast and easy reproducible 3D bronchial model growing at the air-liquid interface: which critical culture parameters must be controlled?","volume":"144","author":"Lechanteur","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.tiv.2026.106272_bb0285","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1039\/c9tx00179d","article-title":"Nanoparticle induced barrier function assessment at liquid\u2013liquid and air\u2013liquid interface in novel human lung epithelia cell lines","volume":"8","author":"Leibrock","year":"2019","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tiv.2026.106272_bb0290","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jpba.2009.12.006","article-title":"The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification","volume":"51","author":"Liu","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.tiv.2026.106272_bb0295","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0303-7","article-title":"Lipophilicity and its relationship with passive drug permeation","volume":"28","author":"Liu","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2026.106272_bb0300","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tiv.2017.06.024","article-title":"Mono-(2-ethylhexyl) phthalate induced ROS-dependent autophagic cell death in human vascular endothelial cells","volume":"44","author":"Liu","year":"2017","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2026.106272_bb0305","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/mp4000822","article-title":"Rapid measurement of intracellular unbound drug concentrations","volume":"10","author":"Mateus","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tiv.2026.106272_bb0310","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10611860290007504","article-title":"Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats","volume":"10","author":"Mathia","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.tiv.2026.106272_bb0315","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1007\/s11095-013-1069-5","article-title":"The extracellular microenvironment explains variations in passive drug transport across different airway epithelial cell types","volume":"30","author":"Min","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2026.106272_bb0320","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fbioe.2018.00120","article-title":"In vitro models and on-chip systems: biomaterial interaction studies with tissues generated using lung epithelial and liver metabolic cell lines","volume":"6","author":"Nikolic","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tiv.2026.106272_bb0325","series-title":"OECD Guidelines for the Testing of Chemicals, Section 203: Fish, Acute Toxicity Test","author":"OECD","year":"2019"},{"key":"10.1016\/j.tiv.2026.106272_bb0330","unstructured":"OECD, 2025. Guidance Document on Good In Vitro Method Practices (GIVIMP), Second Edition, Assessment, O.S.O.T.A (Ed.), Paris."},{"key":"10.1016\/j.tiv.2026.106272_bb0335","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1517\/17425247.2013.805743","article-title":"Pharmaceutical applications of the Calu-3 lung epithelia cell line","volume":"10","author":"Ong","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.tiv.2026.106272_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34554-w","article-title":"Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrins","volume":"8","author":"Paczkowska","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2026.106272_bb0345","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejpb.2006.06.005","article-title":"Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions","volume":"64","author":"Palmgr\u00e9n","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.tiv.2026.106272_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122208","article-title":"Development of lung tissue models and their applications","volume":"334","author":"Petpiroon","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.tiv.2026.106272_bb0355","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/minf.201200166","article-title":"The use of rule-based and QSPR approaches in ADME profiling: a case study on Caco-2 permeability","volume":"32","author":"Pham-The","year":"2013","journal-title":"Mol. Inform."},{"key":"10.1016\/j.tiv.2026.106272_bb0360","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/membranes14070157","article-title":"Improving the accuracy of permeability data to gain predictive power: assessing sources of variability in assays using cell monolayers","volume":"14","author":"Pires","year":"2024","journal-title":"Membranes"},{"key":"10.1016\/j.tiv.2026.106272_bb0365","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/acsptsci.4c00607","article-title":"A 3D model of the human lung airway for evaluating permeability of inhaled drugs","volume":"8","author":"Rahman","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.tiv.2026.106272_bb0370","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2020.07.025","article-title":"In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs","volume":"161-162","author":"Sakagami","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tiv.2026.106272_bb0375","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1038\/s41598-021-86037-0","article-title":"Long-term evolution of the epithelial cell secretome in preclinical 3D models of the human bronchial epithelium","volume":"11","author":"Sanchez-Guzman","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2026.106272_bb0380","series-title":"Air Liquid Interface Models: A Collection of Tools to Support Powerful Studies that Mimic in Vivo Models","author":"Sciences, C.L","year":"2021"},{"key":"10.1016\/j.tiv.2026.106272_bb0385","series-title":"Application Properties of Materials Used for Porous Membranes in Cell Culture Inserts","author":"Scott","year":"2013"},{"key":"10.1016\/j.tiv.2026.106272_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113862","article-title":"In vitro and ex vivo models in inhalation biopharmaceutical research \u2014 advances, challenges and future perspectives","volume":"177","author":"Selo","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tiv.2026.106272_bb0395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpb.2023.01.013","article-title":"Air-liquid interface (ALI) impact on different respiratory cell cultures","volume":"184","author":"Silva","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.tiv.2026.106272_bb0400","article-title":"Emerging technologies for in vitro inhalation toxicology","volume":"10","author":"Singh","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.tiv.2026.106272_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121423","article-title":"Mucus-producing epithelial models for investigating the activity of gene delivery systems in the lung","volume":"614","author":"Sonntag","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tiv.2026.106272_bb0410","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"key":"10.1016\/j.tiv.2026.106272_bb0415","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s10194-024-01894-0","article-title":"Regional distribution of unbound eletriptan and sumatriptan in the CNS and PNS in rats: implications for a potential central action","volume":"25","author":"Svane","year":"2024","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.tiv.2026.106272_bb0420","first-page":"120","article-title":"Russell and Burch\u2019s 3Rs then and now: the need for clarity in definition and purpose","volume":"54","author":"Tannenbaum","year":"2015","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.tiv.2026.106272_bb0425","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1208\/s12248-010-9176-2","article-title":"Comparison of drug permeabilities and BCS classification: three lipid-component PAMPA system method versus Caco-2 monolayers","volume":"12","author":"Teksin","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.tiv.2026.106272_bb0430","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ejpb.2008.07.001","article-title":"Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo","volume":"70","author":"Trammer","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.tiv.2026.106272_bb0435","first-page":"56","article-title":"Development and validation of a higher-throughput equilibrium dialysis assay for plasma protein binding","volume":"16","author":"van Liempd","year":"2011","journal-title":"JALA: J. Assoc. Lab. Autom."},{"key":"10.1016\/j.tiv.2026.106272_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/biom12091260","article-title":"Expression and function of ABC transporters in human alveolar epithelial cells","volume":"12","author":"Visigalli","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.tiv.2026.106272_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/ph18010113","article-title":"Two- and three-dimensional culture systems: respiratory in vitro tissue models for chemical screening and risk-based decision making","volume":"18","author":"Wallace","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.tiv.2026.106272_bb0450","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/toxsci\/kfr254","article-title":"Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment","volume":"125","author":"Wetmore","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2026.106272_bb0455","series-title":"A powerful Tool for the Study of Airway Biology: Human Tracheobronchial Epithelial Model Grown at the Air-liquid Interface, Shanghai, China","author":"Xuemei","year":"2021"},{"key":"10.1016\/j.tiv.2026.106272_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073384","article-title":"Airway surface liquid pH regulation in airway epithelium current understandings and gaps in knowledge","volume":"22","author":"Zajac","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2026.106272_bb0465","first-page":"2516","article-title":"pH dependent but not P-gp dependent bidirectional transport study of S-propranolol: the importance of passive diffusion","volume":"32","author":"Zheng","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2026.106272_bb0470","first-page":"265","article-title":"Phenylacetylglutamine and hippuric acid in uremic and healthy subjects","volume":"55","author":"Zimmerman","year":"1990","journal-title":"Nephron"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233326000809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233326000809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:13:14Z","timestamp":1788484394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233326000809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":94,"alternative-id":["S0887233326000809"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2026.106272","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary permeability assessment using two human lung epithelial cell models in air-liquid interface cultures","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2026.106272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106272"}}